LSE:BXP
Beximco Pharmaceuticals Limited · LSE · Healthcare · GBP · FY for 2024
Figures on this page computed 2026-11-08 12:25 UTC
Last close
n/aGBp
Market data
7.6xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- GBp
- computed
- Computed from the filing for 2024
12.7%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- GBp
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
13.1%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- GBp
- Computed from the filing for 2024
- Computed from the filing for 2024
13.8%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- GBp
- Computed from the filing for 2024
- Computed from the filing for 2024
0.13Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- GBp
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- GBp
- computed
6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
Six questions
lens 5 of 9Six questions
5 yes of 5 answered- 1Does it earn money?yes
net margin, read above 0.
- 2Can it pay what it owes?yes
interest coverage, read above 3.
- 3Is it bigger than five years ago?yes
rev growth 5y, read above 0.
- 4Does the profit turn into cash?yes
fcf margin, read above 0.
- 5Is it issuing shares?Not known
share count change yoy, read below 1. We do not hold that figure for this company.
- 6Is it priced under twenty times earnings?yes
pe ratio, read below 20.
1 of these could not be answered. That is not a no: it is a figure we do not hold, and it is left as what it is.
5 of 5 questions answered yes; 1 could not be answered.
5 of 5 questions answered yes; 1 could not be answered.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2024
Does it earn money?13.1%
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- BDT
Can it pay what it owes?7.5x
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- BDT
Is it bigger than five years ago?14.2%
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- BDT
Does the profit turn into cash?13.8%
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- BDT
Is it issuing shares?n/a
The stored value is a zero that stands for missing data rather than a measurement, so we will not place it.
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- BDT
Is it priced under twenty times earnings?7.6x
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- BDT